Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18893649 | 0.85 | POLB (0.72) | POLBCA12CA1CA2CA9 | |
| SCHEMBL2557016 | 0.82 | SCN2A (0.58) | POLBCA12CA1CA2CA9 | |
| SCHEMBL6140639 | 0.79 | MAPT (0.62) | POLBCA12CA1CA2CA9 | |
| SCHEMBL7549606 | 0.79 | MAPT (0.58) | POLBCA12CA1CA2CA9 | |
| SCHEMBL9824170 | 0.79 | ALDH1A1 (0.53) | CA12CA1CA2CA9SCN2A | |
| SCHEMBL6140676 | 0.78 | POLB (0.64) | POLBCA12CA1CA2CA9 | |
| SCHEMBL16395894 | 0.78 | POLB (0.64) | POLBPKMMEN1KMT2AMAPT | |
| SCHEMBL5649903 | 0.77 | POLB (0.62) | POLBPKMMEN1KMT2AMAPT | |
| SCHEMBL16395879 | 0.76 | MEN1 (0.66) | POLBPKMMEN1KMT2AALDH1A1 | |
| SCHEMBL10643664 | 0.75 | SCN2A (0.54) | POLBSCN2APKMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050182260-A1 | Process for the preparation of cyclic imides in the presence of polyphosphoric acid | MERCK PATENT GMBH (DE) | 2005-08-18 | — | — | US | disclosed |
| EP-1506173-A1 | METHOD FOR PRODUCING CYCLIC IMIDES IN THE PRESENCE OF POLYPHOSPHORIC ACID | MERCK PATENT GmbH (DE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097600-A1 | METHOD FOR PRODUCING CYCLIC IMIDES IN THE PRESENCE OF POLYPHOSPHORIC ACID | MERCK PATENT GMBH (DE) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182260-A1 | Process for the preparation of cyclic imides in the presence of polyphosphoric acid | PPIP5K2, ITPA, IPMK | POLB 1147/4885CA12 2651/4885CA1 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.